BIOMAT Database Logo BIOMAT Database Logo

Evaluation of the blue formazan spot test for screening glucose 6 phosphate dehydrogenase deficiency. 1999

A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Hematology Laboratory for Anemia Research, IDIBAPS Hospital Clinic i Provincial, Barcelona, Spain.

Several screening tests for glucose 6 phosphate dehydrogenase (G6PD) deficiency have been reported thus far, and a standardized method of testing was proposed by the International Council for Standardization in Hematology (ICSH). The screening test used in any particular laboratory depends upon a number of factors such as cost, time required, temperature, humidity, and availability of reagents. In this study, a direct comparison between three different G6PD screening methods has been undertaken. In 71 cases (50 hematologically normal volunteers, 9 hemizygous G6PD-deficient males, and 12 heterozygous deficient females), the blue formazan spot test (BFST) was compared with the conventional methemoglobin reduction test (HiRT) and the ICSH-recommended fluorescent spot test (FST-ICSH). In all cases, the results obtained with the three screening tests were correlated with the enzyme activity assayed spectrophotometrically. In hemizygous G6PD-deficient males, all cases were equally detected with the three methods: BFST (4.7-6.64, controls: 11.1-13.4), BMRT (score +3 in all 9 cases), and FST (no fluorescence in 9 cases). In heterozygous G6PD-deficient females, two methods detected 7 out of 12 cases (BFST: 8.71-11.75, controls: 11.1-13.4; and BMRT: score +3 in 7 cases), whereas the FST-ICSH missed all 12 cases that presented a variable degree of fluorescence. Although the sensitivity for G6PD-deficient carrier detection is the same for the BMRT and the BFST, the latter has the advantage of being semiquantitative and not merely qualitative. Unfortunately, none of the three screening tests compared here allowed the detection of the 100% heterozygote carrier state of G6PD deficiency.

UI MeSH Term Description Entries
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D005562 Formazans Colored azo compounds formed by the reduction of tetrazolium salts. Employing this reaction, oxidoreductase activity can be determined quantitatively in tissue sections by allowing the enzymes to act on their specific substrates in the presence of tetrazolium salts. Formazan
D005955 Glucosephosphate Dehydrogenase Deficiency A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia. Deficiency of Glucose-6-Phosphate Dehydrogenase,Deficiency, GPD,Deficiency, Glucosephosphate Dehydrogenase,G6PD Deficiency,GPD Deficiency,Glucose 6 Phosphate Dehydrogenase Deficiency,Glucose-6-Phosphate Dehydrogenase Deficiency,Glucosephosphate Dehydrogenase Deficiencies,Hemolytic Anemia Due to G6PD Deficiency,Deficiencies, G6PD,Deficiencies, GPD,Deficiencies, Glucose-6-Phosphate Dehydrogenase,Deficiencies, Glucosephosphate Dehydrogenase,Deficiency of Glucose 6 Phosphate Dehydrogenase,Deficiency, G6PD,Deficiency, Glucose-6-Phosphate Dehydrogenase,Dehydrogenase Deficiencies, Glucose-6-Phosphate,Dehydrogenase Deficiencies, Glucosephosphate,Dehydrogenase Deficiency, Glucose-6-Phosphate,Dehydrogenase Deficiency, Glucosephosphate,G6PD Deficiencies,GPD Deficiencies,Glucose-6-Phosphate Dehydrogenase Deficiencies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013778 Tetrazolium Salts Quaternary salts derived from tetrazoles. They are used in tests to distinguish between reducing sugars and simple aldehydes, for detection of dehydrogenase in tissues, cells, and bacteria, for determination of corticosteroids, and in color photography. (From Mall's Dictionary of Chemistry, 5th ed, p455) Tetrazolium Salt,Salt, Tetrazolium,Salts, Tetrazolium

Related Publications

A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Mass screening for glucose-6-phosphate dehydrogenase deficiency: improved fluorescent spot test.
October 1985, Clinica chimica acta; international journal of clinical chemistry,
A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
The methylene blue reduction test: evaluation of a screening method for glucose-6-phosphate dehydrogenase deficiency.
November 1974, The American journal of tropical medicine and hygiene,
A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Fluorescent spot test for screening erythrocyte glucose-6-phosphate dehydrogenase deficiency in newborn babies.
June 1970, The Journal of pediatrics,
A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Screening for glucose-6-phosphate dehydrogenase deficiency in haemolytic disorders: the methylene blue reduction test.
September 1979, The West Indian medical journal,
A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Brilliant cresyl blue screening test for demonstrating glucose-6-phosphate dehydrogenase deficiency in red cells.
January 1963, Clinica chimica acta; international journal of clinical chemistry,
A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Screening for glucose-6-phosphate dehydrogenase deficiency.
July 1992, The Journal of pediatrics,
A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Screening for glucose-6-phosphate dehydrogenase deficiency.
January 1973, Israel journal of medical sciences,
A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Screening for glucose-6-phosphate dehydrogenase deficiency.
April 1981, Texas medicine,
A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Modification of neonatal screening test for erythrocyte glucose-6-phosphate dehydrogenase deficiency.
September 1976, Clinica chimica acta; international journal of clinical chemistry,
A Pujades, and M Lewis, and A M Salvati, and S Miwa, and H Fujii, and R Zarza, and R Alvarez, and E Rull, and J L Corrons
Neonatal screening for glucose-6-phosphate dehydrogenase deficiency.
September 1992, The Journal of pediatrics,
Copied contents to your clipboard!